SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-032280
Filing Date
2021-12-22
Accepted
2021-12-22 16:30:12
Documents
14
Period of Report
2021-12-21
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44415
2 ex99-1.htm EX-99.1 9673
  Complete submission text file 0001493152-21-032280.txt   277621

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adxs-20211221.xsd EX-101.SCH 3746
4 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adxs-20211221_def.xml EX-101.DEF 27055
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adxs-20211221_lab.xml EX-101.LAB 37311
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adxs-20211221_pre.xml EX-101.PRE 25670
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5521
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-36138 | Film No.: 211513642
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences